Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies
NCT03881774
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER_GOV
Sponsor class
Conditions
Refractory
Relapsed
B Cell Lymphoma
B Cell Leukemia
Interventions
BIOLOGICAL:
CAR-T cells
Sponsor
Henan Cancer Hospital
Collaborators
[object Object]